Table 1.
Predictor | Incidence of Postoperative AF No./Total (%) | Risk Score | OR (95% CI) | P Value |
---|---|---|---|---|
Age, y | ||||
< 30 | 0 | 0 | 1.74 (1.58 – 1.92) | <0.001 |
30–39 | 2/36 (5.6) | 6 | ||
40–49 | 19/229 (8.3) | 12 | ||
50–59 | 160/795 (20.1) | 18 | ||
60–69 | 378/1145 (33.0) | 24 | ||
70–79 | 377/817 (46.1) | 30 | ||
≥ 80 | 40/68 (58.8) | 36 | ||
Medical history | ||||
Atrial fibrillation | 142/268 (53.0) | 7 | 2.04 (1.52 – 2.75) | <0.001 |
Chronic obstructive pulmonary disease | 137/320 (42.8) | 4 | 1.42 (1.09 – 1.86) | 0.010 |
Concurrent valve surgery | 154/286 (53.9) | 5 | 1.67 (1.25 – 2.23) | <0.001 |
Withdrawal of treatment | ||||
Beta-blockers | 396/784 (50.5) | 7 | 1.95 (1.55 – 2.46) | <0.001 |
ACE-I | 320/692 (46.2) | 5 | 1.65 (1.34 – 2.02) | <0.001 |
Preoperative and postoperative treatment | ||||
Beta-blockers | 228/1289 (17.7) | −7 | 0.50 (0.39 – 0.62) | <0.001 |
ACE-I | 126/626 (20.1) | −5 | 0.61 (0.48 – 0.78) | <0.001 |
Statins | 128/665 (19.3) | −5 | 0.58 (0.46 – 0.74) | <0.001 |
Postoperative Beta-blockers | 51/228 (17.7) | −11 | 0.32 (0.22 – 0.46) | <0.001 |
Other treatment | ||||
Potassium supplementation | 774/2688 (28.8) | −5 | 0.62 (0.49 – 0.79) | <0.001 |
NSAIDs | 173/934 (18.5) | −7 | 0.50 (0.41 – 0.62) | <0.001 |
OR, odds ratio; ACE-I, angiotensin-converting enzyme inhibitor; NSAID, nonsteroidal anti-inflammatory drug.